Overview / Abstract: |
This accredited CME activity, led by Gregory Grabowski, MD, Professor Emeritus at University of Cincinnati College of Medicine, highlights the latest research about Gaucher disease presented at WORLDSymposium 2022 along with expert analysis of its clinical relevance for busy members of the care team to help them care for patients they may encounter with this rare condition. Gaucher disease is a genetic lysosomal storage disorder in which glucocerebroside accumulates in cells and certain organs. The disorder is characterized by bruising, fatigue, anemia, low blood platelet count and enlargement of the liver and spleen. Current therapy options include enzyme replacement therapy or substrate reduction therapy but newer treatment options are in development. Furthermore, there is a genetic link between Gaucher disease and Parkinson’s disease that is currently being investigated. Data on these topics were presented at WORLDSymposium 2022 and discussed by Dr. Grabowski. |
Expiration |
Apr 15, 2023 |
Format |
Webinar / Webcast / Video |
Credits / Hours |
0.25 |
Accreditation |
American Academy of CME |
Presenters / Authors / Faculty |
Gregory A. Grabowski, MD |
Activity Specialities / Related Topics |
Primary Care, Pediatrics, Oncology / Cancer / Radiation Therapy, Nephrology, Internal Medicine, Hematology, Genetics, Gastroenterology / GI |
Sponsors / Supporters / Grant Providers |
Takeda Pharmaceuticals U.S.A. |
Keywords / Search Terms |
CheckRare Gaucher Disease, rare disease, genetic disease, genetic disorder, Gregory Grabowski MD, University of Cincinnati College of Medicine, lysosomal storage disease, lysosomal, enzyme replacement therapy Free CE CME |